ctla4

Showing 1 posts of 1 posts found.

Bristol-Myers Squibb withdraws lung cancer combo therapy marketing application

January 25, 2019
Medical Communications BMS, Merck, Yervoy, ctla4, lung cancer, opdivo

Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …

Latest content